Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network
- PMID: 15223087
- PMCID: PMC2668155
- DOI: 10.1016/j.jsat.2004.03.012
Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network
Abstract
Several instruments for diagnosing substance use disorders (SUD) have been developed, but to date none has emerged as the standard for community-based clinical studies. To select the most suitable SUD diagnostic instrument for its clinical trials, the National Drug Abuse Treatment Clinical Trials Network (CTN) implemented a procedure in which 36 university-based addiction researchers and 62 community-based addiction treatment providers evaluated and ranked five widely recognized diagnostic instruments: (1) the SUD section of the Structured Clinical Interview for DSM-IV (SCID); (2) the SUD section of the Composite International Diagnostic Interview, 2nd ed. (CIDI-2); (3) the SUD section of the Diagnostic Interview Schedule for DSM-IV Diagnosis (DIS-IV); (4) the Diagnostic Statistical Manual-IV Checklist (DSM-IV Checklist); and (5) the Substance Dependence Severity Scale (SDSS). To assist the evaluation and ranking process, key characteristics of each instrument were presented in tabular and narrative formats. Participants ranked each instrument from 1 (most preferred) to 5 (least preferred). The SCID received the best overall mean score (2.24) followed by the CIDI-2 (2.59), DIS (2.94), DSM Checklist (3.40) and the SDSS (3.83). After discussing the pragmatic and scientific advantages and disadvantages of each instrument, the CTN Steering Committee selected the CIDI-2. The selection of the CIDI-2 standardizes the collection of diagnostic data and provides a common diagnostic tool for practitioners and clinical researchers in the CTN. Implications for practice/research collaboration and initiatives are explored.
Figures

Similar articles
-
Comparing the Performance of World Mental Health Composite International Diagnostic Interview Substance Abuse Module in Adolescents to Diagnoses Made by Pediatric Addiction Medicine Specialists.J Addict Med. 2024 Mar-Apr 01;18(2):205-208. doi: 10.1097/ADM.0000000000001271. Epub 2024 Jan 30. J Addict Med. 2024. PMID: 38289239 Free PMC article.
-
[Preliminary comparative study of the personality disorder evaluation DIP instrument with the semi-structured SCID-II interview].Encephale. 2009 Dec;35(6):544-53. doi: 10.1016/j.encep.2008.09.007. Encephale. 2009. PMID: 20004285 French.
-
[Diagnostic structured interviews in child and adolescent's psychiatry].Encephale. 2004 Mar-Apr;30(2):122-34. doi: 10.1016/s0013-7006(04)95422-x. Encephale. 2004. PMID: 15107714 Review. French.
-
Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview.Drug Alcohol Depend. 2020 Nov 1;216:108294. doi: 10.1016/j.drugalcdep.2020.108294. Epub 2020 Sep 15. Drug Alcohol Depend. 2020. PMID: 33007702 Free PMC article.
-
Adolescents and substance-related disorders: research agenda to guide decisions on Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V).Addiction. 2006 Sep;101 Suppl 1:115-24. doi: 10.1111/j.1360-0443.2006.01594.x. Addiction. 2006. PMID: 16930168 Review.
Cited by
-
Intensive motivational interviewing for women with concurrent alcohol problems and methamphetamine dependence.J Subst Abuse Treat. 2014 Feb;46(2):113-9. doi: 10.1016/j.jsat.2013.08.013. Epub 2013 Sep 26. J Subst Abuse Treat. 2014. PMID: 24074649 Free PMC article. Clinical Trial.
-
Latent class analysis of non-opioid dependent illegal pharmaceutical opioid users in Ohio.Drug Alcohol Depend. 2014 Jan 1;134:259-266. doi: 10.1016/j.drugalcdep.2013.10.004. Epub 2013 Oct 23. Drug Alcohol Depend. 2014. PMID: 24210772 Free PMC article.
-
Comparison of opiate-primary treatment seekers with and without alcohol use disorder.J Subst Abuse Treat. 2010 Sep;39(2):114-23. doi: 10.1016/j.jsat.2010.05.008. Epub 2010 Jul 3. J Subst Abuse Treat. 2010. PMID: 20598831 Free PMC article. Clinical Trial.
-
Intensive Motivational Interviewing for Women with Alcohol Problems.Counselor (Deerfield Beach). 2015 Jun;16(3):62-69. Counselor (Deerfield Beach). 2015. PMID: 26236173 Free PMC article.
-
Trajectories of non-prescribed buprenorphine and other opioid use: A multi-trajectory latent class growth analysis.J Subst Use Addict Treat. 2023 Apr;147:208973. doi: 10.1016/j.josat.2023.208973. Epub 2023 Feb 10. J Subst Use Addict Treat. 2023. PMID: 36804351 Free PMC article.
References
-
- Albanese MJ, Bartel RL, Bruno RF, Morgenbesser MW, Schatzberg AF. Comparison of measures used to determine substance abuse in an inpatient psychiatric population. American Journal of Psychiatry. 1994;151:1077–1078. - PubMed
-
- Allen JP, Litten RZ, Anton RF, Cross GM. Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues. Alcoholism: Clinical & Experimental Research. 1994;18:799–812. - PubMed
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: Author; 2000.
-
- Anton RF. Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol. 2001;25:185–188. - PubMed
-
- Chiang CN, Hawks RL. Implications of drug levels in body fluids: Basic concepts. In: Hawks RL, Chaing CN, editors. Urine testing for drugs of abuse. Rockville, MD: Department of Health and Human Services; 1986. (NIDA Research Monograph No. 73,pp. 62– 83)
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical